Search research articles
Contact Us
Filters
Showing results (251-260 of 289) with videos related to
Page
of 29
Sort By:
Frontiers in Molecular Neuroscience
|
December 13, 2021
Non-synaptic Cell-Autonomous Mechanisms Underlie Neuronal Hyperactivity in a Genetic Model of <i>PIK3CA</i>-Driven Intractable Epilepsy
Achira Roy, Victor Z Han, Angela M Bard, et al.
European Journal of Clinical Investigation
|
July 1, 1993
High density lipoprotein subfractions, apolipoprotein A-I containing lipoproteins, lipoprotein (a), and cholesterol ester transfer protein activity in alcoholic women before and after ethanol withdrawal
M Välimäki, J Kahri, K Laitinen, et al.
Journal of Lipid Research
|
October 1, 1995
Lipoprotein lipase gene polymorphisms: associations with myocardial infarction and lipoprotein levels, the ECTIM study. Etude Cas Témoin sur l'Infarctus du Myocarde
R Jemaa, F Fumeron, O Poirier, et al.
Arteriosclerosis and Thrombosis : a Journal of Vascular Biology
|
September 1, 1994
Impact of apolipoprotein E polymorphism on lipoproteins and risk of myocardial infarction. The ECTIM Study
G Luc, J M Bard, D Arveiler, et al.
Metabolism: Clinical and Experimental
|
May 1, 1992
A multicenter comparison of the effects of simvastatin and fenofibrate therapy in severe primary hypercholesterolemia, with particular emphasis on lipoproteins defined by their apolipoprotein composition
J M Bard, H J Parra, R Camare, et al.
Atherosclerosis
|
July 1, 1987
Detection of human apolipoprotein B polymorphic species with one monoclonal antibody (BIP 45) against low density lipoprotein. Influence of this polymorphism on lipid levels and coronary artery stenosis
P Duriez, N Vu Dac, M Koffigan, et al.
European Journal of Clinical Pharmacology
|
January 1, 1989
Effect of simvastatin on plasma lipids, apolipoproteins and lipoprotein particles in patients with primary hypercholesterolaemia
J M Bard, G Luc, P Douste-Blazy, et al.
Antimicrobial Agents and Chemotherapy
|
August 26, 2004
Disruption of the Candida albicans CYB5 gene results in increased azole sensitivity
K M Rogers, C A Pierson, N T Culbertson, et al.
Atherosclerosis
|
December 1, 1991
Lipoprotein particle analysis comparing simvastatin and fenofibrate
J M Bard, H J Parra, G Luc, et al.
The American Journal of Clinical Nutrition
|
July 1, 1991
n-3 polyunsaturated fatty acids raise low-density lipoproteins, high-density lipoprotein 2, and plasminogen-activator inhibitor in healthy young men
F Fumeron, L Brigant, V Ollivier, et al.
Page
of 29
Search research articles
Search
Showing results (251-260 of 289) with videos related to
Sort By:
Page
of 29
Frontiers in Molecular Neuroscience
|
December 13, 2021
Non-synaptic Cell-Autonomous Mechanisms Underlie Neuronal Hyperactivity in a Genetic Model of <i>PIK3CA</i>-Driven Intractable Epilepsy
Achira Roy, Victor Z Han, Angela M Bard, et al.
European Journal of Clinical Investigation
|
July 1, 1993
High density lipoprotein subfractions, apolipoprotein A-I containing lipoproteins, lipoprotein (a), and cholesterol ester transfer protein activity in alcoholic women before and after ethanol withdrawal
M Välimäki, J Kahri, K Laitinen, et al.
Journal of Lipid Research
|
October 1, 1995
Lipoprotein lipase gene polymorphisms: associations with myocardial infarction and lipoprotein levels, the ECTIM study. Etude Cas Témoin sur l'Infarctus du Myocarde
R Jemaa, F Fumeron, O Poirier, et al.
Arteriosclerosis and Thrombosis : a Journal of Vascular Biology
|
September 1, 1994
Impact of apolipoprotein E polymorphism on lipoproteins and risk of myocardial infarction. The ECTIM Study
G Luc, J M Bard, D Arveiler, et al.
Metabolism: Clinical and Experimental
|
May 1, 1992
A multicenter comparison of the effects of simvastatin and fenofibrate therapy in severe primary hypercholesterolemia, with particular emphasis on lipoproteins defined by their apolipoprotein composition
J M Bard, H J Parra, R Camare, et al.
Atherosclerosis
|
July 1, 1987
Detection of human apolipoprotein B polymorphic species with one monoclonal antibody (BIP 45) against low density lipoprotein. Influence of this polymorphism on lipid levels and coronary artery stenosis
P Duriez, N Vu Dac, M Koffigan, et al.
European Journal of Clinical Pharmacology
|
January 1, 1989
Effect of simvastatin on plasma lipids, apolipoproteins and lipoprotein particles in patients with primary hypercholesterolaemia
J M Bard, G Luc, P Douste-Blazy, et al.
Antimicrobial Agents and Chemotherapy
|
August 26, 2004
Disruption of the Candida albicans CYB5 gene results in increased azole sensitivity
K M Rogers, C A Pierson, N T Culbertson, et al.
Atherosclerosis
|
December 1, 1991
Lipoprotein particle analysis comparing simvastatin and fenofibrate
J M Bard, H J Parra, G Luc, et al.
The American Journal of Clinical Nutrition
|
July 1, 1991
n-3 polyunsaturated fatty acids raise low-density lipoproteins, high-density lipoprotein 2, and plasminogen-activator inhibitor in healthy young men
F Fumeron, L Brigant, V Ollivier, et al.
Page
of 29